Maria Ines Mitrani, Chief Science Officer at Organicell Regenerative Medicine, Inc. (BPSR), sold 175,000 shares at $0.27 ($51K) on 2021-05-10, disclosed to the SEC on 2021-05-12.
Open-market sale of $51k BPSR by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.27 | 50,000 | $14K | 26.7% |
| 2 | $0.28 | 25,000 | $7K | 13.8% |
| 3 | $0.34 | 41,783 | $14K | 28.1% |
| 4 | $0.35 | 8,217 | $3K | 5.7% |
| 5 | $0.26 | 50,000 | $13K | 25.7% |
| Total | $0.29 avg | 175,000 |
| $51K |
| 100% |
| Filing → |
| BPSR | SELL | 2021-06-11 | $31K | — | Filing → |
| BPSR | SELL | 2021-06-08 | $34K | — | Filing → |
| BPSR | SELL | 2021-06-03 | $24K | — | Filing → |